//
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure